Article
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
Antimicrobial agents and chemotherapy - 1 Sept 2010
Martel Claire M, Parker Josie E, Bader Oliver, Weig Michael, Gross Uwe, Warrilow Andrew G S, Kelly Diane E, Kelly Steven L
Abstract excerpt
A clinical isolate of Candida albicans was identified as an erg5 (encoding sterol C22 desaturase) mutant in which ergosterol was not detectable and ergosta 5,7-dienol comprised >80% of the total sterol fraction. The mutant isolate (CA108) was resistant to fluconazole, voriconazole, itraconazole, ketoconazole, and clotrimazole (MIC values, 64, 8, 2, 1, and 2 microg ml(-1), respectively); azole resistance could not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.